ArticleFrontiers in immunology2022

An immune risk score predicts progression-free survival of melanoma patients in South China receiving anti-PD-1 inhibitor therapy-a retrospective cohort study examining 66 circulating immune cell subsets.

Peidong Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.